Since 2018, the immunosuppressant drug fingolimod has also been approved for children and adolescents aged 10 years and older whose […]
- Home
- Fingolimod:
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok